Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

Year in Review 2024 - Top Clinical Trials in Neuro-Oncology

Oncology 2024 Year in Review

S. Bagley

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Overview and Updates in Brain Tumors

Henry Friedman

2024 Year in Review: Neuro-oncology Focus: Glioblastoma Trials

Neurology 2024 Year in Review

S. Sengupta

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

BRAF/MEK Targeted Therapy in Adult and Pediatric Glioma: Insights an…

Johns Hopkins

K. Schreck

Diagnosing IDH-Mutant Diffuse Glioma: Recent Classification Updates …

Ashley Aaroe

Vorasidenib for Low Grade Gliomas

Stanford Medicine

T. Cao

Surgical Approaches for Brain Tumors

Dana-Farber Cancer Institute

W. Linda Bi, O. Arnaout

Key Practice-Changing Studies in Neuro-Oncology: Rapid Insights Acro…

Yale Cancer Center

N. Blondin

Getting Ahead of the ALS Curve: Early Detection and Intervention

i3 Health

S. Paganoni

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler